GLAM
FPRX

Gardner Lewis Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Gardner Lewis Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-236,565
Closed -$8.91M – 100
2021
Q1 		$8.91M Buy
+236,565
New +$5.9M 1.6% 24

Gardner Lewis Asset Management's FPRX Position: Q2 2021 in Review

Gardner Lewis Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 236,565 shares — an estimated $8.91M sold.

Gardner Lewis Asset Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $8.91M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Gardner Lewis Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 236,565 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $8.91M.
  • Gardner Lewis Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Five Prime Therapeutics, Inc. position peaked at $8.91M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.